Reply: Pre-Dilation, Oversizing, Annulus Calcification Severity: Impact on Mild Paravalvular Leakage

Tobias Rheude; Michael Joner; Erion Xhepa

doi:10.1016/j.jcin.2020.12.010

Reply: Pre-Dilation, Oversizing, Annulus Calcification Severity: Impact on Mild Paravalvular Leakage

Tobias Rheude, Michael Joner, Erion Xhepa

Klinik für Herz- und Kreislauferkrankungen im Erwachsenenalter

Publikation: Beitrag in Fachzeitschrift › Brief › Begutachtung

Originalsprache	Englisch
Seiten (von - bis)	352-353
Seitenumfang	2
Fachzeitschrift	JACC: Cardiovascular Interventions
Jahrgang	14
Ausgabenummer	3
DOIs	https://doi.org/10.1016/j.jcin.2020.12.010
Publikationsstatus	Veröffentlicht - 8 Feb. 2021

Zugriff auf Dokument

10.1016/j.jcin.2020.12.010

Andere Dateien und Links

Verknüpfung zur Publikation in Scopus

Dieses zitieren

@article{5e612b6cbd90494bb86615b2b6ab1ebe,

title = "Reply: Pre-Dilation, Oversizing, Annulus Calcification Severity: Impact on Mild Paravalvular Leakage",

author = "Tobias Rheude and Michael Joner and Erion Xhepa",

note = "Funding Information: Dr. Joner has received lecture fees and research grants from Edwards Lifesciences and Boston Scientific; and is a consultant for Biotronik and Orbus Neich. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.",

year = "2021",

month = feb,

day = "8",

doi = "10.1016/j.jcin.2020.12.010",

language = "English",

volume = "14",

pages = "352--353",

journal = "JACC: Cardiovascular Interventions",

issn = "1936-8798",

publisher = "Elsevier Inc.",

number = "3",

}

TY - JOUR

T1 - Reply

T2 - Pre-Dilation, Oversizing, Annulus Calcification Severity: Impact on Mild Paravalvular Leakage

AU - Rheude, Tobias

AU - Joner, Michael

AU - Xhepa, Erion

N1 - Funding Information: Dr. Joner has received lecture fees and research grants from Edwards Lifesciences and Boston Scientific; and is a consultant for Biotronik and Orbus Neich. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.

PY - 2021/2/8

Y1 - 2021/2/8

UR - http://www.scopus.com/inward/record.url?scp=85099847178&partnerID=8YFLogxK

U2 - 10.1016/j.jcin.2020.12.010

DO - 10.1016/j.jcin.2020.12.010

M3 - Letter

C2 - 33541548

AN - SCOPUS:85099847178

SN - 1936-8798

VL - 14

SP - 352

EP - 353

JO - JACC: Cardiovascular Interventions

JF - JACC: Cardiovascular Interventions

IS - 3

ER -